FSD PHARMA INC-CLASS B (HUGE) Stock Analyst Ratings
USA - NASDAQ:HUGE - CA35954B4047 - Common Stock
0.0899 USD
-0.01 (-10.1%)
0.0916 USD
+0 (+1.89%)
ChartMill assigns a Buy % Consensus number of 83% to HUGE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.83. This target is 8606.04% above the current price.
HUGE was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about HUGE.
In the previous month the buy percentage consensus was at a similar level.
HUGE was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
FSD PHARMA INC-CLASS B / HUGE FAQ
What do analysts expect the price target to be for FSD PHARMA INC-CLASS B (HUGE)?
7 analysts have analysed HUGE and the average price target is 7.83 USD. This implies a price increase of 8606.04% is expected in the next year compared to the current price of 0.0899.
How do analysts rate FSD PHARMA INC-CLASS B (HUGE)?
The consensus rating for FSD PHARMA INC-CLASS B (HUGE) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed FSD PHARMA INC-CLASS B (HUGE)?
The number of analysts covering FSD PHARMA INC-CLASS B (HUGE) is 7.